Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
440.2 INR | -0.59% | +3.00% | +2.31% |
15/05 | Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion | RE |
25/04 | Transcript : Laurus Labs Limited, Q4 2024 Earnings Call, Apr 25, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.31% | 285.83Cr | |
+32.09% | 69TCr | |
+29.39% | 59TCr | |
-1.34% | 37TCr | |
+20.34% | 33TCr | |
+7.39% | 29TCr | |
+14.25% | 24TCr | |
-3.03% | 21TCr | |
+10.02% | 21TCr | |
+8.49% | 17TCr |
- Stock Market
- Equities
- LAURUSLABS Stock
- News Laurus Labs Limited
- Laurus Labs Pays First Tranche to Acquire Additional Stake in Cell and Gene Therapy Company